Patient characteristics associated with clinical disease progression
| Patient characteristics . | Odds ratio for progression (P value) . |
|---|---|
| Age | |
| <40 | 1.77 (P = .51) |
| 40-59 | 1.48 (P = .50) |
| ≥60 | 1.00 (reference) |
| Sex | |
| Male | 1.65 (P = .25) |
| Female | 1.00 (reference) |
| Clinical stage at the time of diagnosis | |
| Stage I | 1.00 (reference) |
| Stage II | 4.70 (P = .005) |
| Stage ≥III | 12.00 (P < .0001) |
| Expression of IL-17F | |
| IL-17F+ | 2.75 (P = .025) |
| IL-17F− | 1.00 (reference) |
| Patient characteristics . | Odds ratio for progression (P value) . |
|---|---|
| Age | |
| <40 | 1.77 (P = .51) |
| 40-59 | 1.48 (P = .50) |
| ≥60 | 1.00 (reference) |
| Sex | |
| Male | 1.65 (P = .25) |
| Female | 1.00 (reference) |
| Clinical stage at the time of diagnosis | |
| Stage I | 1.00 (reference) |
| Stage II | 4.70 (P = .005) |
| Stage ≥III | 12.00 (P < .0001) |
| Expression of IL-17F | |
| IL-17F+ | 2.75 (P = .025) |
| IL-17F− | 1.00 (reference) |